Related Experiment Video
Updated: Oct 1, 2026
Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Heart rate variability suppression in cancer patients versus non-cancer controls: a systematic review and
Hsiu-Hua Shih1, Hsu-Chieh Chang1,2, Po-Huang Chen3
1School of Nursing, College of Nursing, Taipei Medical University, 250 Wu-Hsing Street, Taipei City, 11031, Taiwan.
Background:
Cancer-associated autonomic dysfunction may suppress heart rate variability (HRV), yet no meta-analysis has pooled between-group differences in established HRV indices across cancer types. This review quantified HRV differences versus non-cancer controls, HRV-fatigue associations, and longitudinal HRV trajectories.
Methods:
PubMed, MEDLINE, CINAHL, Embase, and the Cochrane Library were searched through March 2026. Adults with physician-confirmed malignancy and ECG- or PPG-based HRV were eligible. Because time-domain indices scale with recording length, the DerSimonian-Laird random-effects pool was restricted a priori to short-term resting recordings (5-10 min) with age-matched non-cancer controls (Part A); long-term ambulatory recordings (12-30 h) were reported separately, and remaining studies synthesized narratively (Part B) or longitudinally (Part C). Certainty was assessed using GRADE (PROSPERO CRD42026130103).
Results:
Twenty-eight studies (3232 participants; 9 cancer categories) were included; five met pooling criteria. Cancer patients showed lower SDNN (MD = -14.05 ms [95% CI -18.20, -9.90]), RMSSD (-16.76 ms [-21.23, -12.28]), and pNN50 (-6.05% [-9.36, -2.74]); all p < 0.001, I2 = 22.1-33.7%. HF power was non-significant (p = 0.118). Leave-one-out analyses confirmed robustness, and within-cancer studies consistently showed inverse HRV-fatigue correlations. All pooled outcomes were Very Low certainty.
Conclusions:
Cancer patients show consistently suppressed short-term time-domain HRV, a clinically plausible signal of autonomic impairment. Because it aggregates mechanistically distinct sources (malignancy, cardiotoxicity, perioperative vagal withdrawal, survivorship remodeling), the pooled estimate cannot attribute suppression to any cause, and Very Low certainty precludes recommending HRV as an established clinical biomarker. Treatment-phase-stratified studies with standardized protocols and non-linear indices are needed.
Related Concept Videos
01:31Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
01:30Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
01:17Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
01:19Cardiac Output I:Effect of Heart Rate on Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
01:14Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
01:30Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...